Delivery Order SPE2DB22D2206-SPE2DB25FGG86

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,568.30 delivery order contract is for the supply of Oxycodone HCL 5 mg/5 ml cups, which are medical products used for pain management. The contract has a period of performance through March 2025 and uses a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract provides for the delivery of 4564015075 - Oxycodone HCl 5 mg/5 ml Cup UD 5 ml to support military treatment programs and facilities. The award has a ceiling value of $4,227.05 and an ultimate completion date of March 20, 2024. AmerisourceBergen Drug...
This contract award of $1,871.17 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566380288 OXYCODONE HCL 5 MG/5 ML CUP UD 5ML. The contract is a firm fixed-price delivery order with a completion date of November 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,611.24 firm fixed-price delivery order is for the supply of Oxycodone HCL 5 mg/5 ml cup unit dose 5 ml. The contract has a period of performance through June 16, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of oxycodone hydrochloride 5 mg/5 ml oral solution in 5 ml cups. The contract has a ceiling value of $2,604.60 and a period of performance through April 24, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a delivery order contract with a firm fixed price pricing type. The award is not associated with a set-aside designation....
This federal contract award is for the delivery of Oxycodone HCl 5 mg/5 ml cups in a total amount of $3,702.86. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 31, 2024 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxycodone HCL 100 mg/5 ml concentrate in 30 ml containers, with a ceiling value of $1,960.05 and a completion date of June 30, 2025. The contract is a Firm Fixed Price (FFP) delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of 4564958560 - OXYCODONE HCL 5 MG/5 ML CUP UD 5ML, with a ceiling value of $2,572.88 and a period of performance through June 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 5 mg/5 ml oxycodone hydrochloride cups in 5 ml unit doses, with a completion date of February 15, 2024 and a potential value of $2,025.66. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products to support military treatment programs and facilities. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,211.18 firm fixed-price contract is for the supply of 4565165480 - Oxycodone HCL 5 mg/5 ml cups with a 5 ml dosage. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGG86
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oxycodone HCL 5 mg/5 ml cups. The contract has a firm fixed-price pricing type and a ceiling value of $1,444.26. It is not set aside for any specific business type. The contract appears to be associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award is part of DLA's efforts to ensure the availability of essential medications and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 6/26/25, 10:02 AM